ArticleJournal of molecular medicine (Berlin, Germany)2024

The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cells.

Larissa Nassauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.